loadpatents
name:-0.032678127288818
name:-0.016319990158081
name:-0.024488925933838
Cao; Guoqing Patent Filings

Cao; Guoqing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cao; Guoqing.The latest application filed is for "use of combination of anti-pd-1 antibody and vegfr inhibitor in preparation of drug for treating cancers".

Company Profile
20.13.28
  • Cao; Guoqing - Jiangsu CN
  • Cao; Guoqing - Lianyungang CN
  • CAO; Guoqing - Shanghai CN
  • Cao; Guoqing - Changxing CN
  • Cao; Guoqing - Zhicheng Changxing
  • Cao; Guoqing - Carmel IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof
Grant 11,365,255 - Yuan , et al. June 21, 2
2022-06-21
Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers
App 20220119528 - Sun; Xing ;   et al.
2022-04-21
Cyclic Molecules As Bruton's Tyrosine Kinase Inhibitor
App 20220081445 - WANG; Zhaoyin ;   et al.
2022-03-17
Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers
Grant 11,208,484 - Sun , et al. December 28, 2
2021-12-28
Anti-4-1bb Antibody, Antigen-binding Fragment Thereof And Medical Use Thereof
App 20210363266 - HUANG; Hao ;   et al.
2021-11-25
Use of EZH2 inhibitor combined with BTK inhibitor in preparing drug for treating tumor
Grant 11,065,239 - Ma , et al. July 20, 2
2021-07-20
Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer
Grant 11,000,518 - Jiang , et al. May 11, 2
2021-05-11
Use Of Ezh2 Inhibitor Combined With Btk Inhibitor In Preparing Drug For Treating Tumor
App 20210030736 - MA; Ke ;   et al.
2021-02-04
Anti-CD27 Antibody, Antigen-binding Fragment Thereof, and Medical Use Thereof
App 20210009706 - Huang; Hao ;   et al.
2021-01-14
Pd-l1 Antibody, Antigen-binding Fragment Thereof And Medical Application Thereof
App 20200399375 - Qu; Xiangdong ;   et al.
2020-12-24
Use Of Kor Agonist In Combination With Mor Agonist In Preparing Drug For Treating Pain
App 20200368309 - HUANG; Xiaoxing ;   et al.
2020-11-26
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof
Grant 10,815,304 - Qu , et al. October 27, 2
2020-10-27
Anti-cd40 Antibody, Antigen Binding Fragment Thereof And Medical Use Thereof
App 20200148778 - Yan; Shude ;   et al.
2020-05-14
Anti-gitr Antibody, Antigen-binding Fragment Thereof, And Pharmaceutical Use Thereof
App 20200131263 - YAN; Shude ;   et al.
2020-04-30
Pharmaceutical Composition Containing Mor Agonist And Kor Agonist, And Uses Thereof
App 20200054594 - NIU; Zhuolu ;   et al.
2020-02-20
Medical Use Of Anti-c Met Antibody-cytotoxic Drug Conjugate
App 20200054764 - SUN; Xing ;   et al.
2020-02-20
Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers
App 20200040078 - SUN; Xing ;   et al.
2020-02-06
Uses Of Egfr/her2 Inhibitor Combined With Pyrimidine-type Anti-metabolic Drug
App 20190358212 - ZOU; Jianjun ;   et al.
2019-11-28
Pd-1 Antibody, Antigen-binding Fragment Thereof, And Medical Application Thereof
App 20190309069 - YUAN; Jijun ;   et al.
2019-10-10
Use Of Combination Of Vegfr Inhibitor And Parp Inhibitor In Preparation Of Medicament For Treating Gastric Cancer
App 20190275021 - JIANG; Jiahua ;   et al.
2019-09-12
Anti-cd27 Antibody, Antigen-binding Fragment Thereof, And Medical Use Of Same
App 20190225698 - YAN; Shude ;   et al.
2019-07-25
Use Of Tyrosine-kinase Inhibitor In Preparing Pharmaceutical Product For Cancer Treatment
App 20190224189 - ZOU; Jianjun ;   et al.
2019-07-25
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof
Grant 10,344,090 - Yuan , et al. July 9, 2
2019-07-09
IL-15 heterodimeric protein and uses thereof
Grant 10,206,980 - Qu , et al. Feb
2019-02-19
Pd-l1 Antibody, Antigen-binding Fragment Thereof And Medical Application Thereof
App 20180334504 - QU; Xiangdong ;   et al.
2018-11-22
IL-17A binding agent and uses thereof
Grant 9,862,765 - Zhang , et al. January 9, 2
2018-01-09
Method for recycling lead oxide-containing waste material
Grant 9,828,653 - Pan , et al. November 28, 2
2017-11-28
Method for directly recovering lead oxide used for a lead-acid battery cathode from waste lead paste
Grant 9,828,654 - Pan , et al. November 28, 2
2017-11-28
Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof
Grant 9,637,484 - Peng , et al. May 2, 2
2017-05-02
Il-15 Heterodimeric Protein And Uses Thereof
App 20170020963 - QU; Xiangdong ;   et al.
2017-01-26
Pd-1 Antibody, Antigen-binding Fragment Thereof, And Medical Application Thereof
App 20160376367 - Yuan; Jijun ;   et al.
2016-12-29
Human Relaxin Analogue, Pharmaceutical Composition Of Same, And Pharmaceutical Application Of Same
App 20160326230 - ZHANG; Lianshan ;   et al.
2016-11-10
Il-17a Binding Agent And Uses Thereof
App 20160289321 - ZHANG; Lianshan ;   et al.
2016-10-06
Method For Recycling Lead Oxide-containing Waste Material
App 20160160315 - Pan; Junqing ;   et al.
2016-06-09
Method For Directly Recovering Lead Oxide Used For A Lead-acid Battery Cathode From Waste Lead Paste
App 20160160316 - Pan; Junqing ;   et al.
2016-06-09
Cycloalkyl Acid Derivative, Preparation Method Thereof, And Pharmaceutical Application Thereof
App 20160108035 - PENG; Jianbiao ;   et al.
2016-04-21
Compounds and methods for treating dislipidemia
Grant 7,749,992 - Cao , et al. July 6, 2
2010-07-06
Compounds and methods for treating dyslipidemia
Grant 7,470,705 - Bell , et al. December 30, 2
2008-12-30
Compounds And Methods For Treating Dislipidemia
App 20070254869 - Cao; Guoqing ;   et al.
2007-11-01
Compounds And Methods For Treating Dyslipidemia
App 20070208003 - Bell; Michael Gregory ;   et al.
2007-09-06
Compounds and methods for treating dyslipidemia
App 20070173526 - Bell; Michael Gregory ;   et al.
2007-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed